Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

March 01, 2014 (Vol. 34, No. 5)

Full-Spectrum Contract Manufacturing

  • The global biologics market is expected to reach $239 billion by 2015, $90 billion above the corresponding 2010 figure, reflecting a CAGR of nearly 10%. This growth rate, calculated by BCC Research, pertains to key market segments such as recombinant therapeutic proteins, monoclonal antibodies (mAbs), and vaccines. When ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.